Article Text

Download PDFPDF

Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
  1. P R Lyons,
  2. P K Newman,
  3. M Saunders
  1. Department of Neurology, Middlesbrough General Hospital, Cleveland, UK.


    A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.